Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gary Nelsestuen"'
Autor:
Chris H Wendt, Gary Nelsestuen, Stephen Harvey, Makedonka Gulcev, Matthew Stone, Cavan Reilly
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155724 (2016)
BACKGROUND:Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease with a significant public health burden. Currently there is no biomarker that identifies those at risk of developing COPD, progression of disease or disease phenotypes
Externí odkaz:
https://doaj.org/article/a45f27cb01da479f81d51dfdc03aa3d9
Autor:
Sushrut S. Waikar, Casey M. Rebholz, Zihe Zheng, Shelley Hurwitz, Chi-yuan Hsu, Harold I. Feldman, Dawei Xie, Kathleen D. Liu, Theodore E. Mifflin, John H. Eckfeldt, Paul L. Kimmel, Ramachandran S. Vasan, Joseph V. Bonventre, Lesley A. Inker, Josef Coresh, Vasan S. Ramachandran, Joseph Bonventre, Sushrut Waikar, Venkata Sabbisetti, Jennifer Van Eyk, Dawn Chen, Qin Fu, Hermine Brunner, Vivette D’Agati, Jonathan Barasch, Casey Rebholz, Alan S. Go, Erwin Bottinger, Avelino Teixeira, Ilse Daehn, Mark Molitch, Daniel Batlle, Brad Rovin, Haifeng Wu, Andrew S. Levey, Meredith Foster, Kathleen Liu, Jon Klein, Michael Mauer, Paola Fioretto, Gary Nelsestuen, Amy Karger, Shawn Ballard, Krista Whitehead, Phyllis Gimotty, Haochang Shou, Xiaoming Zhang, Kellie Ryan, Tom Greene, Robert G. Nelson, John W. Kusek
RATIONALE & OBJECTIVE: Determining whether a change in estimated glomerular filtration rate (eGFR) or albuminuria is clinically significant requires knowledge of short-term within-person variability of the measurements, which few studies have address
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d0c376b8dcb32a771bbb153c716320
http://hdl.handle.net/11577/3303143
http://hdl.handle.net/11577/3303143
Autor:
Gary Nelsestuen, Allan Abbott
Publikováno v:
The FASEB Journal. 3:218-219